Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of gut-acting probiotics is increasingly emerging as a viable option to counteract these disorders.
The Research & Development laboratories of Biofarma Group have developed Respecta, a unique proprietary oral probiotic complex with a proven mechanism of action able to restore and maintain healthy vaginal flora and promote genitourinary tract health, thanks to the synergic action of its key ingredients: probiotics and lactoferrin.
